Jakafi 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FMEC5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $99,173
Award facts
- Contract value 100% obligated
- $99,172.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $99,172.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order, issued on December 22, 2025, with an ultimate completion date of December 23, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The award was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy designed to establish regional prime vendor contractors supporting the Department of Defense's pharmaceutical supply needs.
The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, establishes a ceiling value of $499,999,999 with completion through December 31, 2036, and includes a 30-month base period with three 30-month option periods. Under this vehicle, DMS Pharmaceutical Group serves as a critical pharmaceutical supplier authorized to provide branded and generic prescription drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to military healthcare facilities worldwide. The company's established track record of consistent performance across diverse therapeutic categories and product lines, coupled with its demonstrated capability on recent delivery orders, positions it as a key partner in the Department of Defense's global medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FMEC5?
SPE2DR26FMEC5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FMEC5 worth?
The government has obligated $99,173 on SPE2DR26FMEC5.
Is contract SPE2DR26FMEC5 an order under another contract?
Yes. SPE2DR26FMEC5 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEC5 competed?
The extent of competition for SPE2DR26FMEC5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award